Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

Povidone-Iodine Pleurodesis for Chylothorax in an Extremely Low Birth Weight Infant

  • Kim, Jin Woo (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Jin, Ju Hyun (Department of Pediatrics, National Health Insurance Service Ilsan Hospital) ;
  • Yoon, Shin Won (Department of Pediatrics, National Health Insurance Service Ilsan Hospital)
  • Received : 2019.06.24
  • Accepted : 2019.10.02
  • Published : 2019.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Chylothorax, the accumulation of chyle in the pleural space, is a rare condition, but can lead to serious complications in neonates. Conservative therapy for chylothorax includes enteral feeding with medium-chain triglyceride-enriched diet or parenteral nutrition and administration of octreotide. Surgical management is considered in cases where there is no response to conservative therapy; however, the standardized approach to refractory neonatal chylothorax is still controversial. Chemical pleurodesis can be used when medical therapies for chylothorax fail, to avoid more invasive surgical procedures. We report an extremely preterm infant born at 26 weeks of gestation with refractory chylothorax after patent ductus arteriosus ligation. The infant was successfully treated with pleurodesis using 4% povidone-iodine, without long-term side effects.

Keywords

References

  1. Matsuo S, Takahashi G, Konishi A, Sai S. Management of refractory chylothorax after pediatric cardiovascular surgery. Pediatr Cardiol 2013;34:1094-9. https://doi.org/10.1007/s00246-012-0607-y
  2. Tutor JD. Chylothorax in infants and children. Pediatrics 2014;133:722-33. https://doi.org/10.1542/peds.2013-2072
  3. Bialkowski A, Poets CF, Franz AR; Erhebungseinheit fur seltene padiatrische Erkrankungen in Deutschland Study Group. Congenital chylothorax: a prospective nationwide epidemiological study in Germany. Arch Dis Child Fetal Neonatal Ed 2015;100:F169-72. https://doi.org/10.1136/archdischild-2014-307274
  4. Roehr CC, Jung A, Proquitte H, Blankenstein O, Hammer H, Lakhoo K, et al. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med 2006;32:650-7. https://doi.org/10.1007/s00134-006-0114-9
  5. Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev 2010;9:CD006388.
  6. Murki S, Faheemuddin M, Gaddam P. Congenital chylothorax: successful management with chemical pleurodesis. Indian J Pediatr 2010;77:332-4. https://doi.org/10.1007/s12098-010-0022-4
  7. Cho HJ, Na KJ, Kim DW, Choi YE, Ma JS, Jeong IS. Chemical pleurodesis using a Viscum album extract in infants with congenital chylothorax. Eur J Pediatr 2014;173:823-6. https://doi.org/10.1007/s00431-014-2283-9
  8. Utture A, Kodur V, Mondkar J. Chemical pleurodesis with oxytetracycline in congenital chylothorax. Indian Pediatr 2016;53:1105-6.
  9. Kim JE, Lee C, Park KI, Park MS, Namgung R, Park IK. Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion. Korean J Pediatr 2012;55:177-80. https://doi.org/10.3345/kjp.2012.55.5.177
  10. Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 2003;88:F531-3. https://doi.org/10.1136/fn.88.6.F531
  11. Wagenfeld L, Zeitz O, Richard G. Visual loss after povidone-iodine pleurodesis. N Engl J Med 2007;357:1264-5. https://doi.org/10.1056/NEJMc070128
  12. Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 2006;11:105-8. https://doi.org/10.1111/j.1440-1843.2006.00792.x
  13. Mitanchez D, Walter-Nicolet E, Salomon R, Bavoux F, Hubert P. Congenital chylothorax: what is the best strategy? Arch Dis Child Fetal Neonatal Ed 2006;91:F153-4.
  14. Le Nue R, Molinaro F, Gomes-Ferreira C, Scheib-Brolly C, Escande B, Kuhn P, et al. Surgical management of congenital chylothorax in children. Eur J Pediatr Surg 2010;20:307-11. https://doi.org/10.1055/s-0030-1254164
  15. Arayici S, Simsek GK, Oncel MY, Yilmaz Y, Canpolat FE, Dilmen U. Povidone-iodine for persistent air leak in an extremely low birth weight infant. J Pediatr Surg 2013;48:E21-3.
  16. Hmami F, Oulmaati A, Bouchikhi C, Banani A, Bouharrou A. Congenital chylothorax: rapid and complete response to polyvidone iodine. Arch Pediatr 2014;21:1002-5. https://doi.org/10.1016/j.arcped.2014.06.006
  17. Scottoni F, Fusaro F, Conforti A, Morini F, Bagolan P. Pleurodesis with povidone-iodine for refractory chylothorax in newborns: personal experience and literature review. J Pediatr Surg 2015;50:1722-5. https://doi.org/10.1016/j.jpedsurg.2015.03.069
  18. Resch B, Freidl T, Reiterer F. Povidone-iodine pleurodesis for congenital chylothorax of the newborn. Arch Dis Child Fetal Neonatal Ed 2016;101:F87-8.
  19. Kasdallah N, Kbaier H, Ben Salem H, Blibech S, Bouziri A, Douagi M. Povidone iodine pleurodesis for refractory congenital chylothorax: a review of literature. Tunis Med 2016;94:834.
  20. Borcyk K, Kamil A, Hagerty K, Deer M, Tomich P, Anderson Berry AL. Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report. Clin Case Rep 2018;6:702-8. https://doi.org/10.1002/ccr3.1449

Cited by

  1. Successful Treatment of Intractable Chylothorax with Povidone-Iodine Pleurodesis in Extremely Preterm Infant vol.32, pp.1, 2019, https://doi.org/10.14734/pn.2021.32.1.31